LOGIN
Platelet-rich plasma versus autologous whole blood for chronic lateral elbow epicondylitis
April 2013
Platelet-rich plasma versus autologous whole blood for chronic lateral elbow epicondylitis
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial
Am J Sports Med; 2011; 39(10): 2130-2134Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
28 patients with chronic lateral epicondylitis were randomized to receive treatment with either a single injection of 3mL autologous blood or 3mL of platelet rich plasma (PRP) under ultrasound guidance. Patients who received PRP displayed greater VAS pain score improvement at all follow-up visits; however, significance was only observed at 6 week follow up. Additionally, it was found that there we...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.